Stada is making its first play in the US consumer health market after going from strength to strength in Europe in 2020.
With the German firm now ranked as one of Europe’s top-five OTC players, thanks to a combination of acquisitions and organic growth, Stada has its sights set on the US and has taken
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?